95301 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Viral polymerase inhibitors
#4802COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#4803Compounds for the treatment of inflammatory diseases
#4804DIPHENYL SUBSTITUTED ALKANES
#4805Azolylmethylidenehydrazine derivative and use thereof
#4806Antiviral drugs for treatment or prevention of dengue infection
#4807Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
#4808Modulators of ATP-binding cassette transporters
#4809Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#4810Novel Compounds for Enhancing MHC Class II Therapies
#4811Monocyclic heterocycles as kinase inhibitors
#4812N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S
#4813N-PHENYL-METHANAMINE DERIVATIVE AND PESTICIDE CONTAINING IT
#4814Substituted pyridines that are JNK inhibitors
#4815N-amino tetrahydrothiazine derivatives, method of manufacture and use
#4816Pyrimidinediamine kinase inhibitors
#4817Non-Nucleoside Reverse Transcriptase Inhibitors
#48181,3-dihydroxy substituted phenylamide glucokinase activators
#4819CYCLIC AMINOALKYLCARBOXAMIDE DERIVATIVE
#4820Compounds and methods for the diagnosis and treatment of amyloid associated diseases
#4821UREA DERIVATIVES AS ABL MODULATORS
#4822Dipeptide analogs as coagulation factor inhibitors
#4823INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
#4824Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses
#4825Diacylglycerol Acyltransferase Inhibitors
#4826Small molecule Bcl-Xl/Bcl-2 binding inhibitors
#4827NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME
#4828Antidiabetic oxazolidinediones and thiazolidinediones
#4829HIV inhibiting 5-amido substituted pyrimidines
#4830Amide Derivatives as Kinase Inhibitors
#4831COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#4832Substituted Azolin-2-yl-Amino Compounds
#4833BENZOQUINAZOLINE DERIVATIVES
#48341, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
#4835Lactams and uses thereof
#4836Dihydropyridone ureas as P2Xmodulators
#4837Dihydropyridone amides as P2Xmodulators
#4838Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#4839Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#4840NEW COMPOUNDS USEFUL FOR DPP-IV ENZYME INHIBITION
#4841APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#4842Quinazolines useful as modulators of ion channels
#4843Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
#4844Carbazole carboxamide compounds useful as kinase inhibitors
#4845Dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them
#4846Pharmaceutical composition for treating Alzheimer's disease
#4847Sulfonamides as TRPM8 modulators
#4848COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES
#4849Heteroaryl-substituted alkyne compounds and method of use
#4850NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)
#4851Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
#4852Compositions and methods for inhibition of the JAK pathway
#4853Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
#4854Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists
#4855(4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES
#4856Substituted pyrrolidine-2-carboxamides
#4857Novel Heterocyclic Compounds
#4858Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
#4859DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
#4860Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#48612,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
#4862Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
#4863Substituted disulfonamide compounds
#4864Thiazolhydrazides for treatment of neurodegenerative diseases
#4865Small molecule inhibitors of rotamase enzyme activity
#4866Compounds for the treatment of inflammatory disorders
#4867Inhibitors of diacylglycerol acyltransferase
#48682,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives for therapeutic agent of antiinflammatory disease, method thereof for preparation, therapeutic agent for antiinflammatory disease induced by SPC activity containing the same
#4869Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HTantagonists
#4870Benzazepine derivatives for the treatment of neurological disorders
#4871Substituted isoxazoline or enone oxime compound, and pest control agent
#4872Polymorph of a pharmaceutical
#4873Fungicide N-6-membered fused (hetero) aryl-methylene-N-cycloalkyl carboxamide derivatives
#48742,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
#4875Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
#4876Compounds, compositions and methods comprising heteroaromatic derivatives
#4877Pyridinonyl PDK1 inhibitors
#4878TRIAZOLE DERIVATIVES HAVING ANTIFUNGAL ACTIVITY, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#4879Piperazine and Piperidine MGLUR5 Potentiators
#4880Thiadiazole derivatives for the treatment of neuro-degenerative diseases
#4881COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#4882TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT
#4883Heterocyclic compound and use thereof
#4884USE OF HDAC INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL CANCERS
#4885PYRAZOLE INHIBITORS OF WNT SIGNALING
#4886Insecticidal substituted amino heterocyclic and heteroaryl derivatives
#4887Novel Pharmaceutical Compounds
#4888Caspase inhibitors and uses thereof
#4889NOVEL AMIDO DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
#4890Sphingosine Kinase Inhibitors and Methods of Their Use
#4891HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF
#4892NOVEL AROMATIC HETEROCYCLIC CARBOXYLIC ACID AMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS
#4893Oxazolidinone antibiotic derivatives
#4894TRIAMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF CDC25 PHOSPHATASE
#4895Oxime ester photoinitiators
#4896ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES
#4897Fungicide N-5-membered fused heteroaryl-methylene-N-cycloalkyl-carboxamide derivatives
#4898FUNGICIDE 2-PYRIDYL-METHYLENE-THIO CARBOXAMIDE OR 2-PYRIDYL-METHYLENE-N-SUBSTITUTED CARBOXIMIDAMIDE DERIVATIVES
#4899Phenyl-isoxazol-3-ol derivative
#4900Biphenyl derivatives as modulators of voltage gated ion channels
#4901Bridged six-membered ring compounds
#4902Benzimidazoles and analogs thereof as antivirals
#4903CSF-1R inhibitors, compositions, and methods of use
#4904Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
#49052-aminothiazole-4-carboxylic amides as protein kinase inhibitors
#4906Substituted pyrazines as inhibitors of kinase activity
#4907THIAZOLE INHIBITORS OF CYCLOOXYGENASE
#4908Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
#4909Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
#4910Heterocyclic gamma secretase modulators
#4911Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
#4912Case of renin inhibitors
#4913Tetrahydroisoquinoline compound
#4914Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
#4915Di-substituted amides for enhancing glutamatergic synaptic responses
#4916Azadecalin glucocorticoid receptor modulators
#4917THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE
#4918THERAPEUTIC ANTIVIRAL PEPTIDES
#4919Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
#4920Thiazolidine derivatives as orexin receptor antagonists
#4921Process for the preparation of esomeprazole magnesium dihydrate
#4922KINASE KNOCKDOWN VIA ELECTROPHILICALLY ENHANCED INHIBITORS
#4923INHIBITORS OF 11-BETA-HYDROXY STERIOD DEHYDROGENASE TYPE 1
#4924Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
#49258-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
#4926CASPASE INHIBITORS AND USES THEREOF
#4927Cyclopropane compounds and pharmaceutical use thereof
#4928Compounds, compositions and methods
#4929NOVEL BENZAMIDE DERIVATIVES AND PROCESS FOR THE PREPARTION THEREOF
#4930Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds
#4931Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
#4932PROCESS FOR THE PREPARATION OF FORM I AND FORM II OF RITONAVIR
#49332-(BENZIMIDAZOL-1-YL)-N-(4-PHENYLTHIAZOL-2-YL) ACETAMIDE DERIVATIVES
#4934Methods of modulating PPAR gamma-type receptors
#4935Pyrrole derivative having ureido group and aminocarbonyl group as substituents
#4936Hydrazone derivative
#4937Di(arylamino)aryl compounds
#4938Phenylpropionic acid derivative and use thereof
#4939Compounds as cannabinoid receptor ligands and uses thereof
#4940DIAMINE DERIVATIVES
#4941Compounds as calcium channel blockers
#4942Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
#4943Compounds for the treatment of hepatitis C
#49445-phenylthiazole derivatives and use as PI3 kinase inhibitors
#4945Heteroaryl compounds as P2Yreceptor inhibitors
#4946Chemical linkers and conjugates thereof
#4947COMPOUND HAVING THIOL ANCHORING GROUP, METHOD OF SYNTHESIZING THE SAME, AND MOLECULAR ELECTRONIC DEVICE HAVING MOLECULAR ACTIVE LAYER FORMED USING THE COMPOUND
#4948Compositions useful as inhibitors of voltage-gated sodium channels
#4949Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#4950Phosphatidylinositol 3-kinase inhibitors and methods of their use
#4951NK-1 and serotonin transporter inhibitors
#4952PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN
#49532-N-{5-[ [4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
#4954THIADIAZOLE COMPOUND AND USE THEREOF
#4955Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#4956Fused multicyclic compounds as protein kinase inhibitors
#4957POLYMORPHS OF 5--6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROBROMIDE AND PROCESSES FOR PREPARATION THEREOF
#4958QUINOXALINES USEFUL AS INHIBITORS OF PROTEIN KINASES
#4959Antimicrobial Compounds
#4960Carboxylic acid derivatives, their preparation and use
#4961ISOINDOLINONE KINASE INHIBITORS
#4962Aminopyridine Derivatives
#4963Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#4964Heterocyclic GPR40 modulators
#4965SUBSTITUTED PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS
#4966Imidazole based LXR modulators
#4967BENZOTHIAZOLE DERIVATIVES WITH ACTIVITY AS ADENOSINE RECEPTOR LIGANDS
#4968Aminodihydrothiazine derivatives substituted with a cyclic group
#4969N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides
#4970Substituted Pyrrolidine-2-Carboxamides
#4971Methods of Using PI3K and MEK Modulators
#49725-hydroxymethyl-oxazolidin-2-one antibacterials
#4973Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
#4974Compounds as cannabinoid receptor ligands
#4975Compounds as cannabinoid receptor ligands
#4976Pyrimidylmethyl-sulfonamide compounds
#4977Raf Kinase Inhibitors
#4978Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
#4979Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#4980Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
#4981NOVEL PHENYLPROPIONIC ACID DERIVATIVES AS PEROXISOME PROLIFERATOR-ACTIVATED GAMMA RECEPTOR MODULATORS, METHOD OF THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#49826-substituted benzoxazines
#4983Amine derivative having NPY Y5 receptor antagonistic activity
#4984Pyrazolyl-substituted heterocycles and their use as phytosanitary products
#4985Amido Anti-Viral Compounds, Compositions, And Methods Of Use
#4986Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
#4987Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth
#4988Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation
#4989Modulators of LXR
#4990NOVEL ALKYL SUBSTITUTED PIPERIDINE DERIVATIVES AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
#4991Compounds that modulate intracellular calcium
#4992Glucokinase activators
#4993INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITOR EFFECT AS ACTIVE INGREDIENT
#4994Heteroaryl sulfonamides and CCR2
#49951,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
#4996Compounds for modulating integrin CD11b/CD18
#4997Substituted monocyclic CGRP receptor antagonists
#4998Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
#49992-aminothiazole-4-carboxylic amides as protein kinase inhibitors
#5000Anti-Viral Compounds
#5001Substituted arylalkanoic acid derivatives and use thereof
#5002METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG
#5003CONJUGATED SMALL MOLECULES
#5004INSECTICIDAL COMPOUNDS
#5005Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases
#5006Novel Heterocyclic NF-kB Inhibitors
#5007NOVEL HETEROCYCLIC NF-kB INHIBITORS
#5008THIAZOLIDINE DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF
#5009Inhibitors of syk and JAK protein kinases
#5010FUSED BICYCLIC HETEROARYL DERIVATIVE
#5011PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY
#5012AMIDE COMPOUND
#5013HCV inhibiting macrocyclic phenylcarbamates
#5014N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
#5015Inhibitors of ion channels
#5016Substituted 1-(Azolin-2-yl)-Amino-1,2-Heterocyclyl-Ethane Compounds For Combating Pests
#5017Amide derivatives and medicinal use thereof
#5018Inhibitors of papilloma virus
#5019Phenoxypyridinylamide compounds
#50203-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
#5021Methods for the use of inhibitors of cytosolic phospholipase A2
#5022UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF
#5023Substituted acetophenones useful as PDE4 inhibitors
#5024Organic compounds
#5025Targeted nitroxide agents
#5026Pyrimidine derivatives for the prevention of HIV infection
#5027PHOSPHODIESTERASE 4 INHIBITORS
#5028HETEROCYCLIC COMPOUNDS AS CALCIUM CHANNEL BLOCKERS
#5029Heterocyclic compounds and uses thereof in the treatment of sexual disorders
#5030Benzooxazoles as orexin antagonists
#5031HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY
#5032Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
#5033Heterobicyclic carboxamides as inhibitors for kinases
#5034Therapeutic agent for restenosis
#5035Process for the synthesis of biaryl oxazolidinones
#5036Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use
#5037Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#5038Microbiocides
#5039Adamantyl diamide derivatives and uses of same
#5040Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
#5041Cycloalkylidene and heterocycloalkylidene inhibitor compounds
#5042Chemical inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
#50435-FLUORO PYRIMIDINE DERIVATIVES
#5044I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
#5045Arginine derivatives with NP-I antagonistic activity
#5046Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
#5047Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
#50484-HYDROXY-2-OXO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY
#50493-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
#5050PYRAZOLE COMPOUND
#5051Oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity
#5052Pseudoazulenyl nitrones
#5053Heteroaryl-substituted carboxamides and their use as pharmaceuticals
#5054NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION
#5055DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATOR
#5056ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF
#5057HETEROCYCLIDENE-N-(ARYL) ACETAMIDE DERIVATIVE
#5058Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
#5059Heteroarylacrylamides and their use as pharmaceuticals
#5060Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
#5061Fungicide 2-pyridyl-methylene-carboxamide derivatives
#5062Pyrimidine Derivatives
#5063Urea glucokinase activators
#5064Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity
#5065Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
#5066NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS
#5067CHEMICAL COMPOUNDS
#50683-amino-1,2-benzisothiazole compounds for combating animal pest II
#5069Method of screening for inhibitors of glutaminyl cyclase activity
#5070N-(5-Membered Aromatic Ring)-Amido Anti-Viral Compounds
#5071P-38 INHIBITORS
#5072MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
#5073Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
#5074Novel Heterocyclic NF-kB Inhibitors
#5075Therapeutic agents useful for treating pain
#5076Triazinedione derivatives as GABAreceptor modulators
#5077PHARMACEUTICAL COMPOUNDS
#5078Coumarin derivative having antitumor activity
#5079Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof
#5080Benzothiazole cyclobutyl amine derivatives
#5081Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#5082Indane derivatives as modulators of ion channels
#5083THIAZOLO NAPHTHYL ACIDS
#5084Fungicidal N-cycloalkyl-carboxamide derivatives
#5085AZAB I CYCLO [3 . 1 . 0] HEXANE DERIVATIVES AS DOPAMIN D3 RECEPTOR MODULATORS
#50861-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
#5087Quinazolinedione derivatives as TRPA1 modulators
#5088Compounds and compositions as LXR modulators
#5089Methods and Compositions for Modulating Glycosylation
#5090Phenothiazin derivatives, method for the production thereof and use thereof as pharmaceuticals
#5091Thiophenes and uses thereof
#5092HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE
#5093Compounds, compositions and methods
#5094Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#5095Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#5096Ethenyl carboxamide derivatives useful as microbiocides
#5097Therapeutic lactams
#5098Inhibitors of protein kinases
#5099Receptor-type kinase modulators and methods of use
#5100ZIPRASIDONE FREE FROM COLORED IMPURITIES AND A PROCESS FOR ITS PREPARATION